en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
2/2013
vol. 51
 
Share:
Share:
more
 
 
abstract:
Review paper

Takayasu arteritis: is disease activity assessment possible?

Anna Rowińska-Osuch
,
Ewa Więsik-Szewczyk
,
Marzena Olesińska

Reumatologia 2013; 51, 2: 144-150
Online publish date: 2013/04/29
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Takayasu arteritis is a rare disease of large arteries. Its onset is insidious and may be missed while the ongoing inflammation causes irreversible consequences: cardiovascular complications, vessel obstruction, vision loss and hypertension crisis. The disease is systemic; therefore patients are seen by various specialists: rheumatologist, ophthalmologist, cardiologist and surgeon. Current therapy affects only active inflammation whereas prolonged treatment with corticosteroids results in distant side effects and should not be overused. In order to estimate the effectiveness of the treatment and necessity of its modification it is essential to assess the activity of the inflammation.

In a diagnostic procedure ultrasonography (US) and magnetic resonance imaging (MRI) are of significant importance. Positron emission tomography (PET) seems to be sensitive but expensive, is not readily available and requires further validation. Laboratory indicators, such as interleukin 6, 12 and 18, are being checked as biomarkers of active disease but current data come from small studies. Studies on a complex scale assessing disease activity, such as DEI.Tak, are also being carried out. However, none of the present tools is universal.
keywords:

Takayasu arteritis, disease activity, magnetic resonance imaging, positron emission tomography, ultrasonography







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.